Androstenedione Market Size, Share, Growth, and Industry Analysis, By Type (Androstenedione and Androstadienedione), By Application (Arthritis Pharmaceuticals, Fertility Control Pharmaceuticals, Infectious Inflammation Pharmaceuticals, and Others), and Regional Forecast to 2033

ANDROSTENEDIONE MARKET OVERVIEW

The global Androstenedione Market size was valued at USD 205.49 million in 2024 and is projected to reach USD 211.25 Million in 2025, growing to USD 263.47 Million by 2033, with exhibiting CAGR of 2.8% during the forecast period.

Androstenedione is known as an anabolic steroid, a kind of chemical. This is an originator to other hormones such as testosterone and estrogen. It is formed mostly in the adrenal glands, ovaries, and testes of humans and other animals. It is used in the production of hormones related to the development of male sex organs and physical characteristics. It is most frequently used to resolve the cause of symptoms of excess androgens in a woman who has an elevated testosterone level. It is also used in a few other laboratory tests for this purpose.

Rising emphasis on organic supplements and increasing number of citizens prefer a plant-based diet is propelling the market expansion. Rising awareness about the benefits of skin filler among elderly population is enhancing the market growth. Extensive technological evolution is providing many options for companies to expand their market growth.

COVID-19 IMPACT

Androstenedione had a Negative Effect Due to Closure of Fitness Centers during COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The supply chain disruption and increased the rate of certain raw materials that consequently raise the price of ended products. The imposed lockdown has shut down the gyms and fitness centers which in turn has decreased demand for the drugs. Conversely, the pandemic has amplified demand for dietetic supplements and performance-enhancing drugs by drawing attention of the people towards health. Many people are paid attention towards supplements to enhance their immune systems and develop their overall health.

LATEST TREND

"Personalized Nutrition and Customized Supplements Impel Market Growth"

The present trend in the market that is boosting the market growth is the rising concept of personalized nutrition is gaining traction and customers are looking for customized supplements modified to tier specific health goals. Androstenedione manufacturers are discovering personalized preference to fulfill the individual desires. Clients are gravitating towards natural and organic products such as androstenedione supplements. Market players are countering by developing organic formulations to meet up this demand.

ANDROSTENEDIONE MARKET SEGMENTATION

BY TYPE

Based on Type, the global market can be categorized into androstenedione and androstadienedione

• Androstenedione: It is also known as androst-4-ene-3, 17-dione and it is a naturally occuring androstane steroid and a 17-ketosteroid and its key responsibility is the production of estrogen and testosterone.

• Androstadienedione: It is an essential industrial-scale precursor and it has a wide range of steroid hormones within the same estrange and androstane classifications, this drug is used in pharmaceutical intermediates.

BY APPLICATION

Based on application, the global market can be categorized into arthritis pharmaceuticals, fertility control pharmaceuticals, infectious inflammation pharmaceuticals, and others

• Arthritis Pharmaceuticals: It is consumed to treat pain and reduce fever or inflammation and is also employed for management and prevention of heart attacks, strokes and chest pain.

• Fertility Control Pharmaceuticals: This medicine refers to methods and devices which use the 4-AD chemical to avert unwanted pregnancies.

• Infectious Inflammation Pharmaceuticals: This medication is useful to regulate hormone levels and improve reproductive health.

• Others: There are other types of application areas such as athletes, who are looking to improve muscle recovery or individuals seeking to enhance their overall health and well-being.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

DRIVING FACTORS

"Increasing Demand for Dietary Supplements Enhances the Market Growth"

The growing attribute in the androstenedione market growth is the rising demand for dietary supplements by the end-users. This product is broadly used to improve energy, muscle mass, and athletic performance. People are inclining towards such dietary supplements for improving their overall health and well-being is increasing demand for the drugs. This supplement is highly used particularly in developed countries where lifestyles have become sedentary and often lack essential nutrients in their diets. This has increased the requirement for the drugs as a natural add-on that can advance energy levels and promote muscle growth.

"Rising Awareness about Benefits Physical Activities to Expand the Market"

Another growing factor for the market expansion is the rising knowledge about the benefits of sports and fitness activities. The growing physical activities have also contributed to the rising demand for such drugs. Many athletes and fitness enthusiasts draw on androstenedione to develop their physical performance, because it is believed to enhance endurance, strength, and power. Furthermore, the growing geriatric people have also extensively determined the demand for such supplements. Due to the aging of the population, the requirement for supplements that can improve muscle strength and cognitive function is estimated to increase.

RESTRAINING FACTOR

"Regulatory Concerns and Side Effects Hamper Market Growth"

The impeding factor that can obstruct the market growth is the rising regulatory concern and side effects. The US Food and Drug Administration (FDA) have prohibited the retailing of such chemical a in the U.S., alluding to concerns about its safety and efficiency. This drug is identified to have several side-effects which can risk the users’ health. Some of the side effects associated with the androstenedione use include risk of heart disease, liver damage, and hormonal imbalances. There is also a risk of such drugs interacting with other medications or supplements that can have adverse reactions. Hence, the risk associated with the substance is hindering the market enlargement.

OPPORTUNITY

"Advancements in Technology for Production Could be an Opportunity for the Market Growth"

The technological advancements and growing demand for plant-based supplements are major growth opportunities for the market. Technology is playing a vital role in advancing the production and development of plant-based supplements, which can offer a safe and natural replacement to traditional synthetic supplements. In addition, advancements in extraction and purification technologies are making it simpler to extract and refine androstenedione from plant sources.

CHALLENGE

"Negative Promotion of the Drugs Could Be a Budding Challenge for Market Growth"

Some risk associated with this market which can hamper the market expansion. The unfavorable effects of androstenedione include constant increase in serum estrogen and increase in serum luteinizing hormone, lean muscle mass, and bone growth problem in children are the challenges for the market development. Furthermore, pregnant women are warned from taking these pills as they are linked with higher risks of labor and cause of miscarriage.

REGIONAL INSIGHTS

• NORTH AMERICA

North America is showing high market growth because of the presence of major pharmaceutical companies in this region. The increasing activities on research and development are fueling the market expansion. The rising pervasiveness of hormone-related disorders and the growing geriatric population have further propelled the market growth. The United States androstenedione market is the main contributor to e-scrap generation in this region. The presence of advanced recycling technologies and the rising consideration of sustainable practices create a favorable environment for the progress of the market in North America.

• EUROPE

Europe is experiencing considerable market enlargement owing to the subsistence of advanced pharmaceutical infrastructure and a strong importance on technological innovation. The region’s robust healthcare system and increasing spending in drug development have produced a favorable environment for the enlargement of the market. Furthermore, rising consciousness about the hormonal imbalance disorders and the availability of advanced treatment options have led to an upsurge in the demand for the drugs.

• ASIA

The Asia Pacific is dominating the androstenedione market share because of the subsistence of numerous emerging economies including China and India. These countries are having a large population and a growing demand for healthcare services are fueling the market growth. These countries have witnessed a rising rate for various reproductive disorders that pushes the market growth. In addition, the increasing consciousness about family planning and the need for population control has increased demand for fertility control planning in the region.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market through Investment in R&D and Market Strategies"

Major firms are investing significantly in research and development to improve their solution and to be in the competition through adoption of technological advancements. Many market players use other business practices including acquisitions, merger, and partnership. They are utilizing the new advanced technologies for production and development of new products to stay ahead in the market.

LEADING COMPANIES

• BIOVET (Bulgaria)
• Indo Phyto Chemicals (India)
• Sito Bio (China)
• Goto Pharmaceutical (China)
• Tianjin King York (China)
• Jiufu (China)
• Yongning Pharma (China)
• Jiangxi Hongyuan Pharmaceutical (China)
• Kaizon (India)
• Xi’an Gaoyuan Bio-Chem (China)
• Dongyao Pharmaceutical (China)
• Huazhong Pharmaceutical (China)
• Darui (China)
• Danjiangkou Danao (China)
• Dahua Pharmaceutical (China)

BIOVET (Bulgaria)

BIOVET is a leading biotechnology company specializing in the production of veterinary pharmaceuticals and steroid intermediates, including androstenedione. The company operates multiple production facilities in Europe, with a focus on sustainable fermentation processes. BIOVET's facility in Peshtera, Bulgaria, has an annual fermentation capacity of over 500,000 liters, making it one of the largest producers of steroid intermediates in Eastern Europe. The company adheres to Good Manufacturing Practices (GMP) and complies with stringent European Union regulations for steroid production.

Indo Phyto Chemicals (India)

Indo Phyto Chemicals (IPC) is a prominent manufacturer of plant-derived steroid intermediates, including androstenedione. The company has a production capacity of over 200 metric tons per year for steroidal raw materials, supplying both pharmaceutical and nutraceutical industries globally. IPC sources its raw materials primarily from Dioscorea (wild yam) and soybeans, which are used in the bioconversion process to extract androstenedione. The company exports to more than 40 countries, with key markets in North America, Europe, and Southeast Asia.

KEY INDUSTRY DEVELOPMENT

May 2022: Darui announced the launch of its new androstenedione supplement that is designed to maintain muscle growth and advance athletic performance.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The androstenedione market is experiencing momentous growth because of the rising demand for dietary supplements by the end-users and the rising knowledge about the benefits of sports and fitness activities. However despite challenges that are the rising regulatory concern and side effects that pose a roadblock to the market expansion, the key players are spending significant amounts in research and development to improve their solution and to be in the competition through adoption of technological advancements. The technological integration and growing demand for plant-based diets are foremost growth opportunities for the market.